Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

147009 Press Releases
DateTitleCompany
06 Dec 16 Now, a Whole New View About Managing Anxiety - Special Sunglasses NeuView Incorporated,
Published by
PR Newswire
06 Dec 16 WCCT Global™ Appoints Bill Taaffe as New Chief Executive Officer WCCT Global,
Published by
PR Newswire
06 Dec 16 Finesse® Solutions Launches Second Generation G3Lite+™ SmartController for Single-Use Bioreactor Systems Finesse Solutions, Inc.,
Published by
PR Newswire
06 Dec 16 Inogen Announces Management Transitions and Expanded Board of Directors Inogen, Inc.,
Published by
Business Wire
06 Dec 16 Sanofi: Disclosure of trading in own shares Published by
GlobeNewswire
06 Dec 16 MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016 Published by
GlobeNewswire
06 Dec 16 MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 2016 Conference Published by
GlobeNewswire
06 Dec 16 MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016 MorphoSys AG,
Published by
GlobeNewswire
06 Dec 16 MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 2016 Conference: MorphoSys AG,
Published by
GlobeNewswire
06 Dec 16 CELYAD S.A.: Announces Positive New Data from its CAR-T NKR-2 Phase I Trial at 2016 ASH Annual Meeting CELYAD S.A.,
Published by
GlobeNewswire
06 Dec 16 Teva Receives Positive Outcome for COPAXONE® Label in Europe Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
06 Dec 16 Chi-Med Presents Pre-clinical Data for Selective Syk Inhibitor HMPL-523 at the 2016 American Society of Hematology Annual Meeting Chi-Med,
Published by
Business Wire
06 Dec 16 BRIC Self-Monitoring Blood Glucose Device Market and Forecast Renub Research,
Published by
Renub Research
06 Dec 16 CELYAD S.A.: Announces Positive New Data from its CAR-T NKR-2 Phase I Trial at 2016 ASH Annual Meeting Published by
GlobeNewswire
06 Dec 16 BrainStorm to Host Year End Call with Investors to Discuss Important Corporate Developments BrainStorm Cell Therapeutics Inc.,
Published by
PR Newswire
06 Dec 16 BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Waldenström’s Macroglobulinemia at the 2016 American Society of Hematology Annual Meeting Published by
GlobeNewswire
06 Dec 16 Immunohistochemistry Market by Product Application & Drug Testing) End User - Global Forecast to 2021 ReportBuyer,
Published by
PR Newswire
06 Dec 16 Verastem Presents Phase 2 DYNAMO® Clinical Data at ASH 2016 Annual Meeting Verastem, Inc.,
Published by
Business Wire
05 Dec 16 Air Methods Provides Update on Preliminary November Volumes Published by
GlobeNewswire
06 Dec 16 Combined Analysis of Oral Epigenetic Therapy, CC-486, Demonstrated Hematologic Responses in Patients Who Received Prior Epigenetic Hypo-Methylating Agents (HMA) Celgene Corporation,
Published by
Business Wire
06 Dec 16 The Eye Doctors Host an Event on December 7 to Celebrate the Launch of Their Men’s Premier Red Bull Eyewear Line Published by
GlobeNewswire
06 Dec 16 Karyopharm Presents Updated Phase 1b STOMP Data at the American Society of Hematology 2016 Annual Meeting Published by
GlobeNewswire
06 Dec 16 Sunesis Pharmaceuticals Announces Presentation of Updated Results from the VALOR Trial Examining Overall Survival in Patients Age 60 Years and Older with Relapsed/Refractory AML at the ASH Annual Meeting Published by
GlobeNewswire
06 Dec 16 H3 Biomedicine Announces Data from Lead Development Program of H3B-8800 in Pre-Clinical Models of Hematologic Cancers H3 Biomedicine Inc.,
Published by
Business Wire
06 Dec 16 Tomorrow: Immunomic Therapeutics Participating in Cost of Care Discussion at The Washington Post Immunomic Therapeutics, Inc.,
Published by
Business Wire
06 Dec 16 Cornerstone Pharmaceuticals, Inc. Presents Phase I Data on CPI-613 in Acute Myeloid Leukemia (AML) and T-Cell Non-Hodgkin's Lymphoma (T-cell NHL) at ASH 2016 Cornerstone Pharmaceuticals,
Published by
PR Newswire
06 Dec 16 Actinium Highlights Results from Phase 1 Clinical Trial of Actimab-A at 58th American Society of Hematology Annual Meeting Published by
GlobeNewswire
06 Dec 16 Agios Announces New Clinical Data from Dose-Escalation Portion of Phase 1 Trial of Single Agent AG-120 Showing Durable Molecular Responses in Patients with Advanced Hematologic Malignancies Published by
GlobeNewswire
06 Dec 16 China Glaucoma Surgery Devices Market Outlook to 2022 Reportlinker,
Published by
PR Newswire
06 Dec 16 Nordic Nanovector: Betalutin® in Combination with rituximab Demonstrates Synergistic Anti-Tumour Effect in Preclinical non-Hodgkin Lymphoma Model Nordic Nanovector,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.